Phase I/Ib Trial of TIraGolumab, AtEzolizumab, and RadScopal Radiation in Patients With Advanced Solid Malignancies (TIGER)
Latest Information Update: 29 Apr 2025
At a glance
- Drugs Atezolizumab (Primary) ; Tiragolumab (Primary)
- Indications Cervical cancer; Head and neck cancer; Lung cancer; Oesophageal cancer; Solid tumours; Squamous cell cancer
- Focus Adverse reactions
- Acronyms TIGER
Most Recent Events
- 24 Apr 2025 Status changed from not yet recruiting to recruiting.
- 09 Jan 2025 New trial record